With twelve state attorneys general putting another roadblock to the merger of Paramount Skydance with Warner Bros. Discovery ...

IBM stock plunged 25% after weak Q2 pre-results as spending shifts to AI hardware. What's next for Big Blue? Seeking Alpha ...

Abbott (ABT) reports Q2 earnings July 15; see EPS/revenue forecasts, analyst outlook on Exact Sciences MCED test, and what to ...

Roche (RHHBY) wins FDA priority review for a label expansion for Biogen (BIIB)-partnered kidney disease drug Gazyva with a ...

ASML raised its sales forecast and plans to expand capacity after strong AI demand, while various other chipmakers saw stock ...

Cautious take on CoreWeave, Inc.’s neocloud outlook for H2: margin expansion doubts, guidance credibility, interest burden, ...

Oxford Square Capital blends CLO equity and leveraged loans but faces software exposure and high leverage. Click to read in ...

PayPal receives a $60.50/share joint acquisition offer from Stripe and Advent, a 28% premium valuing the company at over $53B ...

Kiniksa Pharmaceuticals is anchored by Arcalyst, the only FDA-approved therapy for recurrent pericarditis, driving robust ...

ASML (ASML) raised its 2026 forecast for the second time this year and said it plans to expand capacity on the back of AI ...

Goldman Sachs Q2 FY2026 results: 38% earnings growth, $31B private credit, 130% equity underwriting surge, bigger ...

Fabrinet is a critical supplier to the AI and data center ecosystem, yet its stock has lagged AI peers, up just 0.7% YTD. I ...